nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant therapy for non-responders to reduced doses of hepatitis B vaccine during infancy
|
Arya, S.C. |
|
1991 |
9 |
8 |
p. 604- 1 p. |
artikel |
2 |
Alpha-antigen derived from Mycobacterium kansasii; gene cloning and expression in Escherichia coli or Mycobacterium bovis BCG; potential application in M. kansasii disease diagnosis or recombinant vaccine; DNA sequence
|
|
|
1991 |
9 |
8 |
p. 602- 1 p. |
artikel |
3 |
Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic
|
Alm, Richard A. |
|
1991 |
9 |
8 |
p. 588-594 7 p. |
artikel |
4 |
Anthrax vaccines: past, present and future
|
Turnbull, Peter C.B. |
|
1991 |
9 |
8 |
p. 533-539 7 p. |
artikel |
5 |
Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes
|
Kit, Malon |
|
1991 |
9 |
8 |
p. 564-572 9 p. |
artikel |
6 |
Calendar
|
|
|
1991 |
9 |
8 |
p. 608- 1 p. |
artikel |
7 |
Escherichia hermannii (ATCC 33651) polysaccharide-protein conjugates: comparison of two conjugation methods for the induction of humoral responses in mice
|
Jacques, I. |
|
1991 |
9 |
8 |
p. 559-563 5 p. |
artikel |
8 |
Failure to induce cytomegalovirus immunity with its envelope antigen injected without adjuvants
|
Kameoka, Junichi |
|
1991 |
9 |
8 |
p. 605-606 2 p. |
artikel |
9 |
Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted
|
Brown, A.L. |
|
1991 |
9 |
8 |
p. 595-601 7 p. |
artikel |
10 |
Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens
|
Soulié, J.C. |
|
1991 |
9 |
8 |
p. 545-548 4 p. |
artikel |
11 |
Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers
|
Kusov, Yu.Yu. |
|
1991 |
9 |
8 |
p. 540-541 2 p. |
artikel |
12 |
M-protein and N-protein of cat infectious-peritonitis virus and DNA sequence; used in vaccine and live recombinant vector
|
|
|
1991 |
9 |
8 |
p. 603- 1 p. |
artikel |
13 |
New nucleic acid encoding Eimeria tenella protein; and derived vector, host cell, polypeptides and antibody, useful in vaccine against fowl coccidiosis; DNA sequence
|
|
|
1991 |
9 |
8 |
p. 603- 1 p. |
artikel |
14 |
One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine
|
Chutivongse, Supawat |
|
1991 |
9 |
8 |
p. 573-576 4 p. |
artikel |
15 |
Pasteurella haemolytica proteins and genes; used for producing vaccine to protect animals especially cattle from respiratory disease e.g. pneumonia
|
|
|
1991 |
9 |
8 |
p. 602- 1 p. |
artikel |
16 |
Perspective on the development of vaccines against Lyme disease
|
Edelman, R. |
|
1991 |
9 |
8 |
p. 531-532 2 p. |
artikel |
17 |
Pneumococcal vaccination of elderly individuals
|
Fattal-German, Michèle |
|
1991 |
9 |
8 |
p. 542-544 3 p. |
artikel |
18 |
Preparation of vaccine against RNA virus e.g. picornavirus, orthomyxovirus, retrovirus comprises infecting BHK21 cell culture, separating intact cell nuclei from cytoplasmic fraction and precipitating antigenic proteins
|
|
|
1991 |
9 |
8 |
p. 602- 1 p. |
artikel |
19 |
Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes
|
Carlsson, U. |
|
1991 |
9 |
8 |
p. 577-580 4 p. |
artikel |
20 |
Pure amphiphilic glycoprotein antigen from Plasmodium falciparum; for presentation of a vaccine, diagnosis and treatment of malaria; monoclonal antibody production; hybridoma construction
|
|
|
1991 |
9 |
8 |
p. 603- 1 p. |
artikel |
21 |
Rabies control in the Republic of the Philippines: benefits and costs of elimination
|
Fishbein, Daniel B. |
|
1991 |
9 |
8 |
p. 581-587 7 p. |
artikel |
22 |
Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees
|
Perrin, Pierre |
|
1991 |
9 |
8 |
p. 549-558 10 p. |
artikel |
23 |
Recombinant vaccine against cattle leukemia virus; containing envelope glycoprotein gp51 and gp30 fusion protein expressed in Saccharomyces cerevisiae
|
|
|
1991 |
9 |
8 |
p. 602- 1 p. |
artikel |
24 |
Recombinant vaccinia virus with Japanese-encephalitis virus NS1 gene; expression of nonconstitutional protein-1, protein-2 in infected cell culture
|
|
|
1991 |
9 |
8 |
p. 602- 1 p. |
artikel |
25 |
Statistical evaluation of working standards of oral polio vaccines and frequency distribution of titres beyond the fiducial limits
|
Arya, S.C. |
|
1991 |
9 |
8 |
p. 604- 1 p. |
artikel |